Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment
Laura J. Havrilesky, Stephanie Lim, Jessie Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui‐Chen Yang, F. Reed Johnson, Juan Marcos González, Shelby D. Reed
Topics & Concepts
MedicinePARP inhibitorOvarian cancerMaintenance therapyOncologyCancer therapyInternal medicinePoly ADP ribose polymeraseCancerChemotherapyPolymeraseBiochemistryGeneChemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentEconomic and Financial Impacts of Cancer